search
Back to results

Correction of Myopia Evaluation Trial 2 (COMET2)

Primary Purpose

Myopia

Status
Completed
Phase
Phase 3
Locations
United States
Study Type
Interventional
Intervention
Progressive Addition Lenses (PALs)
Single Vision Lenses (SVLs)
Sponsored by
Jaeb Center for Health Research
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Myopia focused on measuring Myopia, Progressive Addition Lenses (PALs), Single Vision Lenses (SVLs), Accommodative lags, Near esophoria, Refractive error

Eligibility Criteria

8 Years - 11 Years (Child)All SexesDoes not accept healthy volunteers

Inclusion Criteria: Refractive error determined by cycloplegic autorefraction which meets all of the following: Spherical equivalent: -0.50 to -3.00 D in both eyes Astigmatism <= 1.5 D in both eyes Anisometropia <= 1.00 D difference between eyes in spherical equivalent Visual acuity is at least 20/20 with best subjective refraction in both eyes Accommodative response at near (33 cm) is less than 2.0D by non-cycloplegic autorefraction Near esophoria (>= 2.0 PD) present by alternate prism and cover test (APCT) at near using best refractive correction determined from non-cycloplegic subjective refraction Exclusion Criteria: Strabismus present by cover-uncover test at far, near, and/or near with +2.00D over best subjective refraction Current or prior use of PALs, bifocals, or contact lenses in either eye (prior or current use of SVLs is allowed)

Sites / Locations

  • University of Alabama- Birmingham, School of Optometry
  • Southern California College of Optometry
  • Indiana School of Optometry
  • New England College of Optometry
  • Ohio State University College of Optometry
  • Family Eye Group
  • Pennsylvania College of Optometry
  • University of Houston College of Optometry

Arms of the Study

Arm 1

Arm 2

Arm Type

Active Comparator

Active Comparator

Arm Label

Progressive addition lenses (PALs)

Single vision lenses (SVLs)

Arm Description

Varilux Ellipse progressive addition lenses (PALs) with a +2.00 D addition

Single vision lenses

Outcomes

Primary Outcome Measures

Distribution of Change in Spherical Equivalent Refractive Error From Baseline to 3 Years
Measured in diopters (D) using cycloplegic refraction sphere (amount of myopia) and cylinder (amount of astigmatism at an angle (axis)). Spherical equivalent (SE) is the sphere plus 1/2 the cylinder. For baseline and each time point, a SE was calculated for each eye for each of the five trials of cycloplegic autorefraction; the median for each eye was averaged to obtain the SE used for analysis. Change was calculated as SE at baseline minus SE at 3 years. A negative value indicates that the myopia worsened; a positive value indicates that it improved.
Mean Change in Spherical Equivalent Refractive Error From Baseline to 3 Years
Measured in diopters (D) using cycloplegic refraction sphere (amount of myopia) and cylinder (amount of astigmatism at an angle (axis)). Spherical equivalent (SE) is defined as the sphere plus 1/2 the cylinder. For baseline and each time point, a SE was calculated for each eye for each of the five trials of cycloplegic autorefraction; the median for each eye was averaged to obtain the SE used for analysis. Change was calculated as SE at baseline minus SE at 3 years. A negative value indicates that the myopia worsened; a positive value indicates that it improved.

Secondary Outcome Measures

Distribution of Spherical Equivalent Refractive Error at 3 Years
Measured in diopters (D) using cycloplegic refraction sphere (amount of myopia) and cylinder (amount of astigmatism at an angle (axis)). Spherical equivalent (SE) is defined as the sphere plus 1/2 the cylinder. A SE was calculated for each eye for each of the five trials of cycloplegic autorefraction, and the median for each eye was averaged to obtain the SE used for analysis.
Mean Spherical Equivalent Refractive Error at 3 Years
Measured in diopters (D) using cycloplegic refraction sphere (amount of myopia) and cylinder (amount of astigmatism at an angle (axis)). Spherical equivalent (SE) is defined as the sphere plus 1/2 the cylinder. A SE was calculated for each eye for each of the five trials of cycloplegic autorefraction, and the median for each eye was averaged to obtain the SE used for analysis.
Distribution of Change in Spherical Equivalent Refractive Error From Baseline to 3 Years According to Baseline Characteristics
Measured in diopters (D) using cycloplegic refraction sphere (amount of myopia) and cylinder (amount of astigmatism at an angle (axis)). Spherical equivalent (SE) is defined as the sphere plus 1/2 the cylinder. For baseline and 3 years, a SE was calculated for each eye for each of the five trials of cycloplegic autorefraction; the median for each eye was averaged to obtain the SE used for analysis. Change was calculated as SE at baseline minus SE at 3 years. A negative value indicates that the myopia worsened; a positive value indicates that it improved.
Mean Change in Spherical Equivalent Refractive Error From Baseline to 3 Years According to Baseline Characteristics
Measured in diopters (D) using cycloplegic refraction sphere (amount of myopia) and cylinder (amount of astigmatism at an angle (axis)). Spherical equivalent (SE) is defined as the sphere plus 1/2 the cylinder. For baseline and 3 years, a SE was calculated for each eye for each of the five trials of cycloplegic autorefraction; the median for each eye was averaged to obtain the SE used for analysis. Change was calculated as SE at baseline minus SE at 3 years. A negative value indicates that the myopia worsened; a positive value indicates that it improved.
Mean Change in Spherical Equivalent Refractive Error From Baseline to 1 Year
Measured in diopters (D) using cycloplegic refraction sphere (amount of myopia) and cylinder (amount of astigmatism at an angle (axis)). Spherical equivalent (SE) is defined as the sphere plus 1/2 the cylinder. For baseline and 1 year, a SE was calculated for each eye for each of the five trials of cycloplegic autorefraction; the median for each eye was averaged to obtain the SE used for analysis. Change was calculated as SE at baseline minus SE at 1 year. A negative value indicates that the myopia worsened; a positive value indicates that it improved.
Mean Change in Spherical Equivalent Refractive Error From Baseline to 2 Years
Measured in diopters (D) using cycloplegic refraction sphere (amount of myopia) and cylinder (amount of astigmatism at an angle (axis)). Spherical equivalent (SE) is defined as the sphere plus 1/2 the cylinder. For baseline and 2 years, a SE was calculated for each eye for each of the five trials of cycloplegic autorefraction; the median for each eye was averaged to obtain the SE used for analysis. Change was calculated as SE at baseline minus SE at 2 years. A negative value indicates that the myopia worsened; a positive value indicates that it improved.
Excellent Spectacle Compliance
Spectacle compliance was assessed on a five-point Likert scale: always, 5; often, 4; sometimes, 3; rarely, 2; and never, 1. Excellent compliance indicates that for the specified period (during school, after school, on weekends), spectacles were estimated at all visits to have been worn either always or often.

Full Information

First Posted
April 28, 2006
Last Updated
July 15, 2016
Sponsor
Jaeb Center for Health Research
Collaborators
National Eye Institute (NEI)
search

1. Study Identification

Unique Protocol Identification Number
NCT00320593
Brief Title
Correction of Myopia Evaluation Trial 2
Acronym
COMET2
Official Title
Correction of Myopia Evaluation Trial 2 (COMET2): A Randomized Trial of the Effect of Progressive Addition Lenses Versus Single Vision Lenses on Low Myopia Associated With Large Accommodative Lags and Near Esophoria in Children
Study Type
Interventional

2. Study Status

Record Verification Date
July 2016
Overall Recruitment Status
Completed
Study Start Date
April 2005 (undefined)
Primary Completion Date
March 2010 (Actual)
Study Completion Date
March 2010 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Jaeb Center for Health Research
Collaborators
National Eye Institute (NEI)

4. Oversight

Data Monitoring Committee
Yes

5. Study Description

Brief Summary
The purpose of the study is to determine if progressive addition lenses (PALs) versus single vision lenses (SVLs) slow the progression of low myopia in children with poor accommodative responses (i.e., large accommodative lags) and near esophoria.
Detailed Description
Myopia is a significant public health problem that affects at least 34% of children in the United States and a much higher percentage in Asia. It is a predisposing factor for retinal detachment, myopic retinopathy, and glaucoma, thus contributing to loss of vision and blindness. As might be expected for such a prevalent condition, treatment costs are high. If interventions to retard myopia progression are successful, sight-threatening complications might be avoided and costs should be reduced. The study has been designed as a simple trial that, other than the type of lenses being determined through the randomization process and the addition of accommodation testing using an autorefractor, largely approximates standard clinical practice. Screening consists of non-cycloplegic procedures of subjective refraction, testing of oculomotor alignment, and testing of accommodative response using the Grand Seiko autorefractor. Patients who appear to be eligible for the randomized trial will be tested with their eyes dilated to determine whether refractive error in each eye is within the eligibility range for the randomized trial. Patients will be randomized to either progressive addition lenses (PALs) with a +2.00 D addition or to single vision lenses (SVLs). Children will have three years of follow up, with visits every 6 months. The primary outcome visit is timed 3 years from randomization, with the primary analysis being a comparison of the average change from baseline to 3 years in amount of myopia between children in the single-vision lens group and the children in the progressive-addition lens group. The primary outcome is change in spherical equivalent refractive error (SER) in diopters (D) as measured by cycloplegic autorefraction. A separate ancillary study nested within the screening process will collect data on two additional methods of measuring accommodation, Monocular Estimate Method (MEM) retinoscopy and Nott retinoscopy. The aim of the ancillary study to help determine whether a simple, effective measure exists that can be easily used by clinicians to identify children with reduced accommodative response who, if they have low myopia and esophoria, might benefit from the treatment with PALs.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Myopia
Keywords
Myopia, Progressive Addition Lenses (PALs), Single Vision Lenses (SVLs), Accommodative lags, Near esophoria, Refractive error

7. Study Design

Primary Purpose
Treatment
Study Phase
Phase 3
Interventional Study Model
Parallel Assignment
Masking
ParticipantCare ProviderInvestigator
Allocation
Randomized
Enrollment
118 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Progressive addition lenses (PALs)
Arm Type
Active Comparator
Arm Description
Varilux Ellipse progressive addition lenses (PALs) with a +2.00 D addition
Arm Title
Single vision lenses (SVLs)
Arm Type
Active Comparator
Arm Description
Single vision lenses
Intervention Type
Device
Intervention Name(s)
Progressive Addition Lenses (PALs)
Intervention Description
Varilux Ellipse progressive addition lenses (PALs) with a +2.00 D addition
Intervention Type
Device
Intervention Name(s)
Single Vision Lenses (SVLs)
Intervention Description
Single vision lenses
Primary Outcome Measure Information:
Title
Distribution of Change in Spherical Equivalent Refractive Error From Baseline to 3 Years
Description
Measured in diopters (D) using cycloplegic refraction sphere (amount of myopia) and cylinder (amount of astigmatism at an angle (axis)). Spherical equivalent (SE) is the sphere plus 1/2 the cylinder. For baseline and each time point, a SE was calculated for each eye for each of the five trials of cycloplegic autorefraction; the median for each eye was averaged to obtain the SE used for analysis. Change was calculated as SE at baseline minus SE at 3 years. A negative value indicates that the myopia worsened; a positive value indicates that it improved.
Time Frame
Baseline to 3 years
Title
Mean Change in Spherical Equivalent Refractive Error From Baseline to 3 Years
Description
Measured in diopters (D) using cycloplegic refraction sphere (amount of myopia) and cylinder (amount of astigmatism at an angle (axis)). Spherical equivalent (SE) is defined as the sphere plus 1/2 the cylinder. For baseline and each time point, a SE was calculated for each eye for each of the five trials of cycloplegic autorefraction; the median for each eye was averaged to obtain the SE used for analysis. Change was calculated as SE at baseline minus SE at 3 years. A negative value indicates that the myopia worsened; a positive value indicates that it improved.
Time Frame
3 years
Secondary Outcome Measure Information:
Title
Distribution of Spherical Equivalent Refractive Error at 3 Years
Description
Measured in diopters (D) using cycloplegic refraction sphere (amount of myopia) and cylinder (amount of astigmatism at an angle (axis)). Spherical equivalent (SE) is defined as the sphere plus 1/2 the cylinder. A SE was calculated for each eye for each of the five trials of cycloplegic autorefraction, and the median for each eye was averaged to obtain the SE used for analysis.
Time Frame
3 years
Title
Mean Spherical Equivalent Refractive Error at 3 Years
Description
Measured in diopters (D) using cycloplegic refraction sphere (amount of myopia) and cylinder (amount of astigmatism at an angle (axis)). Spherical equivalent (SE) is defined as the sphere plus 1/2 the cylinder. A SE was calculated for each eye for each of the five trials of cycloplegic autorefraction, and the median for each eye was averaged to obtain the SE used for analysis.
Time Frame
3 years
Title
Distribution of Change in Spherical Equivalent Refractive Error From Baseline to 3 Years According to Baseline Characteristics
Description
Measured in diopters (D) using cycloplegic refraction sphere (amount of myopia) and cylinder (amount of astigmatism at an angle (axis)). Spherical equivalent (SE) is defined as the sphere plus 1/2 the cylinder. For baseline and 3 years, a SE was calculated for each eye for each of the five trials of cycloplegic autorefraction; the median for each eye was averaged to obtain the SE used for analysis. Change was calculated as SE at baseline minus SE at 3 years. A negative value indicates that the myopia worsened; a positive value indicates that it improved.
Time Frame
Baseline to 3 years
Title
Mean Change in Spherical Equivalent Refractive Error From Baseline to 3 Years According to Baseline Characteristics
Description
Measured in diopters (D) using cycloplegic refraction sphere (amount of myopia) and cylinder (amount of astigmatism at an angle (axis)). Spherical equivalent (SE) is defined as the sphere plus 1/2 the cylinder. For baseline and 3 years, a SE was calculated for each eye for each of the five trials of cycloplegic autorefraction; the median for each eye was averaged to obtain the SE used for analysis. Change was calculated as SE at baseline minus SE at 3 years. A negative value indicates that the myopia worsened; a positive value indicates that it improved.
Time Frame
Baseline to 3 years
Title
Mean Change in Spherical Equivalent Refractive Error From Baseline to 1 Year
Description
Measured in diopters (D) using cycloplegic refraction sphere (amount of myopia) and cylinder (amount of astigmatism at an angle (axis)). Spherical equivalent (SE) is defined as the sphere plus 1/2 the cylinder. For baseline and 1 year, a SE was calculated for each eye for each of the five trials of cycloplegic autorefraction; the median for each eye was averaged to obtain the SE used for analysis. Change was calculated as SE at baseline minus SE at 1 year. A negative value indicates that the myopia worsened; a positive value indicates that it improved.
Time Frame
Baseline to 1 year
Title
Mean Change in Spherical Equivalent Refractive Error From Baseline to 2 Years
Description
Measured in diopters (D) using cycloplegic refraction sphere (amount of myopia) and cylinder (amount of astigmatism at an angle (axis)). Spherical equivalent (SE) is defined as the sphere plus 1/2 the cylinder. For baseline and 2 years, a SE was calculated for each eye for each of the five trials of cycloplegic autorefraction; the median for each eye was averaged to obtain the SE used for analysis. Change was calculated as SE at baseline minus SE at 2 years. A negative value indicates that the myopia worsened; a positive value indicates that it improved.
Time Frame
Baseline to 2 years
Title
Excellent Spectacle Compliance
Description
Spectacle compliance was assessed on a five-point Likert scale: always, 5; often, 4; sometimes, 3; rarely, 2; and never, 1. Excellent compliance indicates that for the specified period (during school, after school, on weekends), spectacles were estimated at all visits to have been worn either always or often.
Time Frame
Baseline to 3 years

10. Eligibility

Sex
All
Minimum Age & Unit of Time
8 Years
Maximum Age & Unit of Time
11 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Refractive error determined by cycloplegic autorefraction which meets all of the following: Spherical equivalent: -0.50 to -3.00 D in both eyes Astigmatism <= 1.5 D in both eyes Anisometropia <= 1.00 D difference between eyes in spherical equivalent Visual acuity is at least 20/20 with best subjective refraction in both eyes Accommodative response at near (33 cm) is less than 2.0D by non-cycloplegic autorefraction Near esophoria (>= 2.0 PD) present by alternate prism and cover test (APCT) at near using best refractive correction determined from non-cycloplegic subjective refraction Exclusion Criteria: Strabismus present by cover-uncover test at far, near, and/or near with +2.00D over best subjective refraction Current or prior use of PALs, bifocals, or contact lenses in either eye (prior or current use of SVLs is allowed)
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Jane E Gwiazda, Ph.D.
Organizational Affiliation
New England College of Optometry
Official's Role
Study Chair
First Name & Middle Initial & Last Name & Degree
Wendy L Marsh-Tootle
Organizational Affiliation
University of Alabama at Birmingham School of Optometry
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Ruth E Manny
Organizational Affiliation
University of Houston College of Optometry
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Erik M Weissberg
Organizational Affiliation
New England College of Optometry
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
David I Silbert
Organizational Affiliation
Family Eye Group
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Don W Lyon
Organizational Affiliation
Indiana University School of Optometry
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Mitchell M Scheiman
Organizational Affiliation
Pennsylvania College of Optometry
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Marjean T Kulp
Organizational Affiliation
Ohio State University
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Susan A Cotter
Organizational Affiliation
Southern California College of Optometry at Marshall B. Ketchum University
Official's Role
Principal Investigator
Facility Information:
Facility Name
University of Alabama- Birmingham, School of Optometry
City
Birmingham
State/Province
Alabama
ZIP/Postal Code
35294
Country
United States
Facility Name
Southern California College of Optometry
City
Fullerton
State/Province
California
ZIP/Postal Code
92831-1699
Country
United States
Facility Name
Indiana School of Optometry
City
Bloomington
State/Province
Indiana
ZIP/Postal Code
47405
Country
United States
Facility Name
New England College of Optometry
City
Boston
State/Province
Massachusetts
ZIP/Postal Code
02215-3468
Country
United States
Facility Name
Ohio State University College of Optometry
City
Columbus
State/Province
Ohio
ZIP/Postal Code
43210-1280
Country
United States
Facility Name
Family Eye Group
City
Lancaster
State/Province
Pennsylvania
ZIP/Postal Code
17601
Country
United States
Facility Name
Pennsylvania College of Optometry
City
Philadelphia
State/Province
Pennsylvania
ZIP/Postal Code
19141
Country
United States
Facility Name
University of Houston College of Optometry
City
Houston
State/Province
Texas
ZIP/Postal Code
77204-2020
Country
United States

12. IPD Sharing Statement

Citations:
PubMed Identifier
19214130
Citation
Correction of Myopia Evaluation Trial 2 Study Group for the Pediatric Eye Disease Investigator Group; Manny RE, Chandler DL, Scheiman MM, Gwiazda JE, Cotter SA, Everett DF, Holmes JM, Hyman LG, Kulp MT, Lyon DW, Marsh-Tootle W, Matta N, Melia BM, Norton TT, Repka MX, Silbert DI, Weissberg EM. Accommodative lag by autorefraction and two dynamic retinoscopy methods. Optom Vis Sci. 2009 Mar;86(3):233-43. doi: 10.1097/OPX.0b013e318197180c.
Results Reference
result
PubMed Identifier
21282579
Citation
Correction of Myopia Evaluation Trial 2 Study Group for the Pediatric Eye Disease Investigator Group. Progressive-addition lenses versus single-vision lenses for slowing progression of myopia in children with high accommodative lag and near esophoria. Invest Ophthalmol Vis Sci. 2011 Apr 25;52(5):2749-57. doi: 10.1167/iovs.10-6631.
Results Reference
result

Learn more about this trial

Correction of Myopia Evaluation Trial 2

We'll reach out to this number within 24 hrs